Cargando…
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2
Autores principales: | Wildemann, Brigitte, Jarius, Sven, Lehmann, Lorenz H., André, Florian, Frey, Norbert, Schnitzler, Paul, Jäger, Laura, Gumbinger, Christoph, Viehöver, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494626/ https://www.ncbi.nlm.nih.gov/pubmed/34617145 http://dx.doi.org/10.1007/s00415-021-10779-0 |
Ejemplares similares
-
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
por: Jarius, S., et al.
Publicado: (2017) -
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS
por: Gahlen, Anna, et al.
Publicado: (2017) -
Reverse Takotsubo Cardiomyopathy in the Setting of Acute Asthma Exacerbation
por: Khan, Muhammad A, et al.
Publicado: (2021) -
Meta-analysis of incidence and outcomes of life-threatening arrhythmias in takotsubo cardiomyopathy
por: Rathore, Sawai Singh, et al.
Publicado: (2022) -
Takotsubo Cardiomyopathy in a Patient with Previously Undiagnosed Hypertrophic Cardiomyopathy with Latent Obstruction
por: Arakawa, Kentaro, et al.
Publicado: (2018)